Clinical trial
Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI…
NCT00463710 · State University of New York at Buffalo, Other · Completed
Key facts
| NCT number | NCT00463710 |
|---|---|
| Title | Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS |
| Official title | Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With Relapsing-remitting and Secondary-progressive Multiple Sclerosis |
| Lead sponsor | State University of New York at Buffalo, Other |
| Collaborators | Biogen Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Avonex® monotherapy (6.0 MIU administered i.m. each week) |
| Enrollment | 150 |
| Start date | Jun 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Apr 20, 2007 |
| Last update posted | Dec 28, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: